Louis van de Locht

A Novel Method to Compensate for Different Amplification Efficiencies between Patient DNA Samples in Quantitative Real-Time PCR

Jules P.P. Meijerink, Caroline M.P.W. Mandigers, Louis van de Locht et al. · Journal of Molecular Diagnostics · 2001 · 308 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +12

The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia

Bryan Linggi, Carsten Müller‐Tidow, Louis van de Locht et al. · Nature Medicine · 2002 · 257 citations

Medicine, Molecular Biology, Molecular Genetics +14

Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes

Carla M. van Herpen, Maaike W.G. Looman, Marijke I. Zonneveld et al. · Clinical Cancer Research · 2004 · 88 citations · Full text

Life Sciences, Immunology, Oncology +17

Expression of <i>C‐IAP1</i>, <i>C‐IAP2</i> and <i>SURVIVIN</i> discriminates different types of lymphoid malignancies

Aniek O. de Graaf, J. Han van Krieken, Evelyn Tönnissen et al. · British Journal of Haematology · 2005 · 43 citations · Full text

Life Sciences, Hematology, Oncology +17

Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein

Genyan Yang, Waleed Khalaf, Louis van de Locht et al. · Molecular and Cellular Biology · 2005 · 41 citations · Full text

Life Sciences, Genetics, Oncology +16